Patents by Inventor Daisuke Kamimura

Daisuke Kamimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220145584
    Abstract: A compaction management system includes a position calculation unit that, when a bucket is pressed against a compaction target ground, calculates a position of the bucket, a rolling compaction force calculation unit that, when the bucket is pressed against the compaction target ground, calculates a rolling compaction force applied to the compaction target ground using the attitude of the machine body, the attitude of the attachment, a pressure of a cylinder, and dimensions of the attachment, a rolling compaction record creation unit that creates a rolling compaction record in which the position calculated by the position calculation unit is associated with the rolling compaction force calculated by the rolling compaction force calculation unit, and a storage control unit that causes a storage device to store the rolling compaction record created by the rolling compaction record creation unit.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 12, 2022
    Applicant: KOBELCO CONSTRUCTION MACHINERY CO., LTD.
    Inventors: Sho FUJIWARA, Yusuke KAMIMURA, Yoichiro YAMAZAKI, Koji YAMASHITA, Daisuke NODA, Hideki YOSHIHARA
  • Publication number: 20210405011
    Abstract: The present invention pertains to a medicine, said medicine comprising as an active ingredient a substance which suppresses the expression of at least one molecule selected from the group consisting of TMEM5, VSTM2L, C2CDD4D, VSTM2A, LY6G6C and ADRA2C or inhibits the activity thereof, for preventing and/or treating at least one disease or symptom selected from the group consisting of progressive multiple sclerosis, gastroenteritis, myocardial disorder and sudden death. Also, the present invention pertains to a method for screening a substance, which is capable of preventing and/or treating at least one disease or symptom selected from the group consisting of progressive multiple sclerosis, gastroenteritis, myocardial disorder and sudden death, with the use of the expression or activity of the aforesaid molecule as an index.
    Type: Application
    Filed: September 2, 2019
    Publication date: December 30, 2021
    Applicant: National University Corporation Hokkaido University
    Inventors: Masaaki Murakami, Daisuke Kamimura
  • Publication number: 20210032633
    Abstract: [Problem] The purpose of the present invention is to provide new treatment targets and treatment methods for chronic inflammatory disease based on a molecular biological mechanism relating to the onset of keloid. [Solution] The present invention relates to a drug for the prevention and/or treatment of chronic inflammatory disease that contains as an active ingredient a substance that suppresses the expression and/or inhibits the activity of a specific NEDD4 splicing variant protein.
    Type: Application
    Filed: February 4, 2018
    Publication date: February 4, 2021
    Applicant: National University Corporation Hokkaido University
    Inventors: Masaaki Murakami, Daisuke Kamimura, Munekumi Fujita
  • Publication number: 20200049696
    Abstract: [Problem] The objectives of the present invention are to provide a method for making an animal that has been stressed, in particular, chronically stressed, affect or develop a specific disease or symptom, and, through elucidating the process from loading stress to affection or onset of the disease or symptom, to provide a useful tool for research and development of preventing or treating methods of the disease or symptom. [Solution] The present invention relates to a method for producing a disease modeling non-human animal having cerebrovascular inflammation, the disease modeling non-human animal, a method for screening a drug using the disease modeling non-human animal, a method for determining the risk of a disease using the presence of cerebrovascular inflammation as an indicator, and a pharmaceutical for preventing and/or treating progressive multiple sclerosis or the like.
    Type: Application
    Filed: March 1, 2018
    Publication date: February 13, 2020
    Applicant: National University Corporation Hokkaido University
    Inventors: Masaaki Murakami, Daisuke Kamimura, Yasunobu Arima